Trial intelligence / Profile preview

MRI Substudy of Metabolic Changes in Prostate Cancer

NCT02102646Phase 4Completed

Sponsor
Herlev Hospital
Start
Apr 2014
Primary completion
Oct 2015
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of triptorelin in prostate cancer (PCa), sponsored by Herlev Hospital. Started Apr 2014; status: completed.

02

Drugs

triptorelin
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT02102646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02102646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call